Suppr超能文献

TRAIL 缺陷小鼠表现出视网膜新生血管消退延迟。

TRAIL-deficient mice exhibit delayed regression of retinal neovascularization.

机构信息

Department of Pediatrics, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239-4197, USA.

出版信息

Am J Pathol. 2009 Dec;175(6):2697-708. doi: 10.2353/ajpath.2009.090099. Epub 2009 Nov 5.

Abstract

While it is well established that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various cell types, the role of TRAIL in regulation of retinal neovascularization (NV) has not been described. Here we determined the role of TRAIL in retinal NV during oxygen-induced retinopathy using TRAIL deficient ((-/-)) mice. TRAIL and its receptor, DR5, were expressed in wild-type retinas at all time points evaluated (postnatal days 12, 17, 21, 24) during oxygen-induced retinopathy and in age-matched room air control animals. Localization of TRAIL(+) cells within the neovascular tufts of hyperoxia- exposed wild-type mice suggested TRAIL plays a role in oxygen-induced retinopathy. Retinal vascular development appeared normal in the TRAIL(-/-) mice, except for a small but significant difference in the capillary-free zone surrounding major arteries. A minimal difference in avascularity was observed at postnatal day 12 in the retinas of TRAIL(-/-) mice after hyperoxia-exposure compared with wild-type mice, suggesting that TRAIL does not play a major role in the vaso-obliterative phase of oxygen-induced retinopathy. However, at the peak of NV, TRAIL(-/-) mice had a significant increase in retinal neovascularization. In addition, when NV naturally regresses in wild-type mice, TRAIL(-/-) mice continued to display significantly high levels of NV. This was attributed to a significant decrease in neovascular tuft cells undergoing apoptosis in TRAIL(-/-) mice. Together, these data strongly suggest that TRAIL plays a role in the control of retinal NV.

摘要

虽然肿瘤坏死因子相关凋亡诱导配体(TRAIL)在各种细胞类型中诱导凋亡已得到充分证实,但 TRAIL 在调节视网膜新生血管(NV)中的作用尚未描述。在这里,我们使用 TRAIL 缺陷型((-/-))小鼠确定了 TRAIL 在氧诱导性视网膜病变中的视网膜 NV 中的作用。TRAIL 和其受体 DR5 在氧诱导性视网膜病变期间(出生后第 12、17、21、24 天)和年龄匹配的空气对照组动物的所有时间点均在野生型视网膜中表达。在高氧暴露的野生型小鼠的新生血管丛中 TRAIL(+)细胞的定位表明 TRAIL 在氧诱导性视网膜病变中发挥作用。TRAIL(-/-)小鼠的视网膜血管发育似乎正常,除了主要动脉周围的无血管区有一个小但显著的差异。与野生型小鼠相比,TRAIL(-/-)小鼠在高氧暴露后第 12 天的视网膜中无血管区域仅观察到微小差异,这表明 TRAIL 在后氧诱导性视网膜病变的血管闭塞期不起主要作用。然而,在 NV 的高峰期,TRAIL(-/-)小鼠的视网膜新生血管显著增加。此外,当 NV 在野生型小鼠中自然消退时,TRAIL(-/-)小鼠仍继续显示出显著高水平的 NV。这归因于 TRAIL(-/-)小鼠中经历凋亡的新生血管丛细胞数量显著减少。综上所述,这些数据强烈表明 TRAIL 在控制视网膜 NV 中发挥作用。

相似文献

1
TRAIL-deficient mice exhibit delayed regression of retinal neovascularization.
Am J Pathol. 2009 Dec;175(6):2697-708. doi: 10.2353/ajpath.2009.090099. Epub 2009 Nov 5.
2
Increased retinal neovascularization in Fas ligand-deficient mice.
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3202-10. doi: 10.1167/iovs.03-0050.
3
Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2175-82. doi: 10.1167/iovs.04-0983.
4
Altered retinal neovascularization in TNF receptor-deficient mice.
Curr Eye Res. 2005 Nov;30(11):1003-13. doi: 10.1080/02713680500330355.
7
Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Arch Ophthalmol. 1996 Oct;114(10):1219-28. doi: 10.1001/archopht.1996.01100140419009.
8
Functional analyses of TNFR2 in physiological and pathological retina angiogenesis.
Invest Ophthalmol Vis Sci. 2013 Jan 9;54(1):211-21. doi: 10.1167/iovs.12-10364.
9
Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy.
Exp Eye Res. 2010 Apr;90(4):493-500. doi: 10.1016/j.exer.2009.12.012. Epub 2010 Jan 11.
10
Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3796-805. doi: 10.1167/iovs.04-0052.

引用本文的文献

4
Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking.
Front Pharmacol. 2022 Jul 5;13:924197. doi: 10.3389/fphar.2022.924197. eCollection 2022.
5
TRAIL protects the immature lung from hyperoxic injury.
Cell Death Dis. 2022 Jul 15;13(7):614. doi: 10.1038/s41419-022-05072-5.
7
Contribution of cell death signaling to blood vessel formation.
Cell Mol Life Sci. 2021 Apr;78(7):3247-3264. doi: 10.1007/s00018-020-03738-x. Epub 2021 Mar 30.
8
Endothelial cell apoptosis in angiogenesis and vessel regression.
Cell Mol Life Sci. 2017 Dec;74(24):4387-4403. doi: 10.1007/s00018-017-2577-y. Epub 2017 Jun 23.
9
Therapeutic applications of TRAIL receptor agonists in cancer and beyond.
Pharmacol Ther. 2015 Nov;155:117-31. doi: 10.1016/j.pharmthera.2015.09.001. Epub 2015 Sep 5.
10
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.
Biomed Res Int. 2015;2015:424019. doi: 10.1155/2015/424019. Epub 2015 Mar 5.

本文引用的文献

1
Is TRAIL the holy grail of cancer therapy?
Apoptosis. 2009 Apr;14(4):607-23. doi: 10.1007/s10495-009-0321-2.
3
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
Nat Rev Drug Discov. 2008 Dec;7(12):1001-12. doi: 10.1038/nrd2637. Epub 2008 Nov 7.
4
MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy.
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4195-202. doi: 10.1167/iovs.07-1491. Epub 2008 May 16.
5
TRAIL and cancer therapy.
Cancer Lett. 2008 May 8;263(1):14-25. doi: 10.1016/j.canlet.2008.02.003. Epub 2008 Mar 10.
6
Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production.
Exp Cell Res. 2008 Apr 15;314(7):1605-16. doi: 10.1016/j.yexcr.2007.12.027. Epub 2008 Jan 16.
7
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Nat Med. 2007 Sep;13(9):1070-7. doi: 10.1038/nm1627. Epub 2007 Sep 2.
8
Unique gene expression profiles of donor-matched human retinal and choroidal vascular endothelial cells.
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2676-84. doi: 10.1167/iovs.06-0598.
9
Death receptor expression and function at the human blood brain barrier.
J Neurol Sci. 2007 Aug 15;259(1-2):53-60. doi: 10.1016/j.jns.2006.08.018. Epub 2007 Mar 28.
10
Development of the retinal vasculature.
Angiogenesis. 2007;10(2):77-88. doi: 10.1007/s10456-007-9065-1. Epub 2007 Feb 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验